CORONAVIRUS/Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
![A COVID-19 vaccine from Taiwan-based Medigen Vaccine Biologics Corp. CNA file photo](https://imgcdn.cna.com.tw/Eng/WebEngPhotos/800/2024/20240202/1024x713_762133283085.jpg)
Taipei, Feb. 2 (CNA) Research conducted by Taiwan's Centers for Disease Control (CDC) showing the locally-produced Medigen COVID-19 vaccine to be as effective as those from Moderna and Pfizer BioNTech is set to be published in a U.S. medical journal.
The research paper will be published in the March issue of Emerging Infectious Diseases, a monthly peer-reviewed journal from the U.S. Centers for Disease Control and Prevention, CDC Deputy Director-General Lo Yi-chun (羅一鈞) told CNA on Friday.
Lo said that the CDC would be publishing the positive results of its research into Medigen Vaccine Biologics Corp.'s protein subunit COVID-19 vaccine, which has been proven to provide 90 percent protection against moderate to severe infections in individuals with three doses.
The protein subunit vaccine is effective against the Omicron subvariant and could protect those receiving immunization from moderate to severe symptoms and even death, according to Lo.
Moreover, the CDC's research is the first large-data set comparison between the strengths of mRNA and protein subunit vaccines, Lo said.
Taiwan's CDC explained that data for the research was collected domestically in Taiwan through the nation's vaccine rollout programs.
The data used for the comparison was based on more than 60 million vaccine jabs received by over 23 million individuals during the mass Omicron community infections that broke out domestically in 2022.
The CDC said the research concluded that the protection provided by Medigen's protein subunit vaccine was equal to that offered by those produced by Moderna and Pfizer BioNTech, which have been proven to be more efficient and long-lasting than those from AstraZeneca (AZ).
The research completely maps out the strength of various vaccine combinations between different age groups and the results are available to experts around the world, the CDC said.
Lo told CNA that the CDC's findings, which have already been made public, were presented at the 30th Conference on Retroviruses and Opportunistic Infections in Seattle last February.
The CDC also advised anyone who received an AZ vaccine as their first two initial inoculation jabs to get additional boosters with next-generation serums.
- COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM
- CDC to buy 5.5 million Moderna JN.1 COVID-19 vaccine shots for October rolloutThe Centers for Disease Control (CDC) on Wednesday announced a plan to purchase 5.5 million doses of the Moderna monovalent JN.1 COVID-19 vaccine, which will be administered, along with the flu vaccine, from Oct. 1.07/10/2024 09:40 PM
- COVID-19 outbreak expected to peak in mid-July in Taiwan: CDCThe COVID-19 outbreak in Taiwan is projected to peak in mid-July, with weekly clinic or emergency room visits expected to soar to 130,000, the Centers for Disease Control (CDC) said Tuesday.07/09/2024 10:42 PM
- Society
Schools, offices in some towns, districts to close Saturday
07/26/2024 10:51 PM - Society
Magnitude 4.6 earthquake shakes Pingtung
07/26/2024 10:30 PM - Politics
Mayor, lawmaker convicted of corruption face different outcomes
07/26/2024 10:02 PM - Society
Typhoon Gaemi causes 8 deaths, 866 injuries as of Friday night
07/26/2024 09:58 PM - Politics
Taichung mayor to resume U.S. trip after typhoon
07/26/2024 09:57 PM